nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GABRG2—Topiramate—obesity	0.0938	0.546	CbGbCtD
Acamprosate—GABRA1—Topiramate—obesity	0.078	0.454	CbGbCtD
Acamprosate—GRM5—hindbrain—obesity	0.0122	0.122	CbGeAlD
Acamprosate—GRIN2C—hindbrain—obesity	0.0093	0.0933	CbGeAlD
Acamprosate—GRIN2D—hindbrain—obesity	0.00865	0.0867	CbGeAlD
Acamprosate—GRIN1—hindbrain—obesity	0.00771	0.0773	CbGeAlD
Acamprosate—GRIN2B—hindbrain—obesity	0.00736	0.0737	CbGeAlD
Acamprosate—GRIN2A—hindbrain—obesity	0.00643	0.0645	CbGeAlD
Acamprosate—SLC36A1—hindbrain—obesity	0.00639	0.064	CbGeAlD
Acamprosate—GRIN2C—adrenal cortex—obesity	0.00477	0.0478	CbGeAlD
Acamprosate—GRM5—endocrine gland—obesity	0.00392	0.0393	CbGeAlD
Acamprosate—GABRA1—hindbrain—obesity	0.00358	0.0359	CbGeAlD
Acamprosate—SLC36A1—adipose tissue—obesity	0.00264	0.0264	CbGeAlD
Acamprosate—SLC36A1—digestive system—obesity	0.00248	0.0249	CbGeAlD
Acamprosate—GRIN1—endocrine gland—obesity	0.00247	0.0248	CbGeAlD
Acamprosate—GRIN2A—adrenal gland—obesity	0.00238	0.0238	CbGeAlD
Acamprosate—SLC36A1—adrenal gland—obesity	0.00236	0.0237	CbGeAlD
Acamprosate—GRIN2B—endocrine gland—obesity	0.00236	0.0237	CbGeAlD
Acamprosate—GRIN2A—endocrine gland—obesity	0.00206	0.0207	CbGeAlD
Acamprosate—SLC36A1—endocrine gland—obesity	0.00205	0.0205	CbGeAlD
Acamprosate—GABRB3—islet of Langerhans—obesity	0.00201	0.0202	CbGeAlD
Acamprosate—GABRB3—respiratory system—obesity	0.0019	0.019	CbGeAlD
Acamprosate—SLC36A1—liver—obesity	0.00185	0.0185	CbGeAlD
Acamprosate—GABRG2—pituitary gland—obesity	0.00168	0.0168	CbGeAlD
Acamprosate—GABRB3—pituitary gland—obesity	0.00129	0.0129	CbGeAlD
Acamprosate—GABRB3—endocrine gland—obesity	0.000998	0.01	CbGeAlD
Acamprosate—GABRB3—liver—obesity	0.0009	0.00902	CbGeAlD
Acamprosate—Chills—Bupropion—obesity	0.00033	0.000678	CcSEcCtD
Acamprosate—Vertigo—Sibutramine—obesity	0.00033	0.000678	CcSEcCtD
Acamprosate—Syncope—Sibutramine—obesity	0.000329	0.000677	CcSEcCtD
Acamprosate—Convulsion—Orlistat—obesity	0.000328	0.000676	CcSEcCtD
Acamprosate—Leukopenia—Sibutramine—obesity	0.000328	0.000675	CcSEcCtD
Acamprosate—Face oedema—Topiramate—obesity	0.000327	0.000672	CcSEcCtD
Acamprosate—Alopecia—Bupropion—obesity	0.000325	0.000668	CcSEcCtD
Acamprosate—Palpitations—Sibutramine—obesity	0.000324	0.000667	CcSEcCtD
Acamprosate—Chest pain—Orlistat—obesity	0.000323	0.000664	CcSEcCtD
Acamprosate—Myalgia—Orlistat—obesity	0.000323	0.000664	CcSEcCtD
Acamprosate—Loss of consciousness—Sibutramine—obesity	0.000322	0.000663	CcSEcCtD
Acamprosate—Mental disorder—Bupropion—obesity	0.000322	0.000662	CcSEcCtD
Acamprosate—Anxiety—Orlistat—obesity	0.000322	0.000661	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00032	0.000659	CcSEcCtD
Acamprosate—Cough—Sibutramine—obesity	0.00032	0.000658	CcSEcCtD
Acamprosate—Malnutrition—Bupropion—obesity	0.00032	0.000658	CcSEcCtD
Acamprosate—Discomfort—Orlistat—obesity	0.000319	0.000656	CcSEcCtD
Acamprosate—Convulsion—Sibutramine—obesity	0.000318	0.000654	CcSEcCtD
Acamprosate—Blood creatinine increased—Topiramate—obesity	0.000317	0.000652	CcSEcCtD
Acamprosate—Hypertension—Sibutramine—obesity	0.000317	0.000651	CcSEcCtD
Acamprosate—Dry mouth—Orlistat—obesity	0.000316	0.000649	CcSEcCtD
Acamprosate—Flatulence—Bupropion—obesity	0.000315	0.000648	CcSEcCtD
Acamprosate—Tension—Bupropion—obesity	0.000314	0.000645	CcSEcCtD
Acamprosate—Dysgeusia—Bupropion—obesity	0.000313	0.000644	CcSEcCtD
Acamprosate—Liver function test abnormal—Topiramate—obesity	0.000312	0.000642	CcSEcCtD
Acamprosate—Myalgia—Sibutramine—obesity	0.000312	0.000642	CcSEcCtD
Acamprosate—Chest pain—Sibutramine—obesity	0.000312	0.000642	CcSEcCtD
Acamprosate—Arthralgia—Sibutramine—obesity	0.000312	0.000642	CcSEcCtD
Acamprosate—Anxiety—Sibutramine—obesity	0.000311	0.00064	CcSEcCtD
Acamprosate—Nervousness—Bupropion—obesity	0.000311	0.000639	CcSEcCtD
Acamprosate—Anaphylactic shock—Orlistat—obesity	0.000309	0.000636	CcSEcCtD
Acamprosate—Back pain—Bupropion—obesity	0.000309	0.000636	CcSEcCtD
Acamprosate—Orthostatic hypotension—Topiramate—obesity	0.000309	0.000636	CcSEcCtD
Acamprosate—Discomfort—Sibutramine—obesity	0.000309	0.000635	CcSEcCtD
Acamprosate—Muscle spasms—Bupropion—obesity	0.000307	0.000632	CcSEcCtD
Acamprosate—Infection—Orlistat—obesity	0.000307	0.000632	CcSEcCtD
Acamprosate—Breast disorder—Topiramate—obesity	0.000306	0.000629	CcSEcCtD
Acamprosate—Dry mouth—Sibutramine—obesity	0.000305	0.000628	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Topiramate—obesity	0.000305	0.000627	CcSEcCtD
Acamprosate—Confusional state—Sibutramine—obesity	0.000302	0.000621	CcSEcCtD
Acamprosate—Skin disorder—Orlistat—obesity	0.0003	0.000618	CcSEcCtD
Acamprosate—Tremor—Bupropion—obesity	0.0003	0.000616	CcSEcCtD
Acamprosate—Gastritis—Topiramate—obesity	0.000299	0.000616	CcSEcCtD
Acamprosate—Anaphylactic shock—Sibutramine—obesity	0.000299	0.000616	CcSEcCtD
Acamprosate—Hyperhidrosis—Orlistat—obesity	0.000299	0.000615	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Topiramate—obesity	0.000298	0.000614	CcSEcCtD
Acamprosate—Infection—Sibutramine—obesity	0.000297	0.000612	CcSEcCtD
Acamprosate—Ill-defined disorder—Bupropion—obesity	0.000297	0.00061	CcSEcCtD
Acamprosate—Anaemia—Bupropion—obesity	0.000296	0.000608	CcSEcCtD
Acamprosate—Shock—Sibutramine—obesity	0.000294	0.000606	CcSEcCtD
Acamprosate—Abdominal distension—Topiramate—obesity	0.000294	0.000606	CcSEcCtD
Acamprosate—Agitation—Bupropion—obesity	0.000294	0.000604	CcSEcCtD
Acamprosate—Thrombocytopenia—Sibutramine—obesity	0.000293	0.000603	CcSEcCtD
Acamprosate—Asthma—Topiramate—obesity	0.000292	0.000601	CcSEcCtD
Acamprosate—Dysphagia—Topiramate—obesity	0.000292	0.000601	CcSEcCtD
Acamprosate—Angioedema—Bupropion—obesity	0.000292	0.000601	CcSEcCtD
Acamprosate—Tachycardia—Sibutramine—obesity	0.000292	0.000601	CcSEcCtD
Acamprosate—Skin disorder—Sibutramine—obesity	0.000291	0.000598	CcSEcCtD
Acamprosate—Eosinophilia—Topiramate—obesity	0.000289	0.000596	CcSEcCtD
Acamprosate—Hyperhidrosis—Sibutramine—obesity	0.000289	0.000595	CcSEcCtD
Acamprosate—Malaise—Bupropion—obesity	0.000288	0.000593	CcSEcCtD
Acamprosate—Vertigo—Bupropion—obesity	0.000287	0.000591	CcSEcCtD
Acamprosate—Syncope—Bupropion—obesity	0.000287	0.00059	CcSEcCtD
Acamprosate—Pancreatitis—Topiramate—obesity	0.000287	0.00059	CcSEcCtD
Acamprosate—Leukopenia—Bupropion—obesity	0.000286	0.000589	CcSEcCtD
Acamprosate—Anorexia—Sibutramine—obesity	0.000285	0.000587	CcSEcCtD
Acamprosate—Angina pectoris—Topiramate—obesity	0.000285	0.000586	CcSEcCtD
Acamprosate—Palpitations—Bupropion—obesity	0.000283	0.000581	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Orlistat—obesity	0.000282	0.00058	CcSEcCtD
Acamprosate—Bronchitis—Topiramate—obesity	0.000281	0.000578	CcSEcCtD
Acamprosate—Loss of consciousness—Bupropion—obesity	0.000281	0.000578	CcSEcCtD
Acamprosate—Insomnia—Orlistat—obesity	0.00028	0.000576	CcSEcCtD
Acamprosate—Hypotension—Sibutramine—obesity	0.00028	0.000575	CcSEcCtD
Acamprosate—Cough—Bupropion—obesity	0.000279	0.000574	CcSEcCtD
Acamprosate—Paraesthesia—Orlistat—obesity	0.000278	0.000571	CcSEcCtD
Acamprosate—Convulsion—Bupropion—obesity	0.000277	0.00057	CcSEcCtD
Acamprosate—Hypertension—Bupropion—obesity	0.000276	0.000568	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Sibutramine—obesity	0.000273	0.000561	CcSEcCtD
Acamprosate—Dyspepsia—Orlistat—obesity	0.000272	0.00056	CcSEcCtD
Acamprosate—Chest pain—Bupropion—obesity	0.000272	0.00056	CcSEcCtD
Acamprosate—Arthralgia—Bupropion—obesity	0.000272	0.00056	CcSEcCtD
Acamprosate—Myalgia—Bupropion—obesity	0.000272	0.00056	CcSEcCtD
Acamprosate—Anxiety—Bupropion—obesity	0.000271	0.000558	CcSEcCtD
Acamprosate—Insomnia—Sibutramine—obesity	0.000271	0.000557	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00027	0.000556	CcSEcCtD
Acamprosate—Pollakiuria—Topiramate—obesity	0.00027	0.000556	CcSEcCtD
Acamprosate—Erectile dysfunction—Topiramate—obesity	0.000269	0.000554	CcSEcCtD
Acamprosate—Discomfort—Bupropion—obesity	0.000269	0.000553	CcSEcCtD
Acamprosate—Decreased appetite—Orlistat—obesity	0.000269	0.000553	CcSEcCtD
Acamprosate—Paraesthesia—Sibutramine—obesity	0.000269	0.000553	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Orlistat—obesity	0.000267	0.000549	CcSEcCtD
Acamprosate—Dyspnoea—Sibutramine—obesity	0.000267	0.000549	CcSEcCtD
Acamprosate—Photosensitivity reaction—Topiramate—obesity	0.000267	0.000549	CcSEcCtD
Acamprosate—Dry mouth—Bupropion—obesity	0.000266	0.000548	CcSEcCtD
Acamprosate—Somnolence—Sibutramine—obesity	0.000266	0.000547	CcSEcCtD
Acamprosate—Weight increased—Topiramate—obesity	0.000266	0.000547	CcSEcCtD
Acamprosate—Weight decreased—Topiramate—obesity	0.000265	0.000544	CcSEcCtD
Acamprosate—Pain—Orlistat—obesity	0.000264	0.000544	CcSEcCtD
Acamprosate—Hyperglycaemia—Topiramate—obesity	0.000264	0.000543	CcSEcCtD
Acamprosate—Dyspepsia—Sibutramine—obesity	0.000263	0.000542	CcSEcCtD
Acamprosate—Confusional state—Bupropion—obesity	0.000263	0.000541	CcSEcCtD
Acamprosate—Pneumonia—Topiramate—obesity	0.000262	0.000539	CcSEcCtD
Acamprosate—Anaphylactic shock—Bupropion—obesity	0.000261	0.000537	CcSEcCtD
Acamprosate—Decreased appetite—Sibutramine—obesity	0.00026	0.000535	CcSEcCtD
Acamprosate—Depression—Topiramate—obesity	0.00026	0.000535	CcSEcCtD
Acamprosate—Infection—Bupropion—obesity	0.000259	0.000533	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Sibutramine—obesity	0.000258	0.000532	CcSEcCtD
Acamprosate—Shock—Bupropion—obesity	0.000257	0.000528	CcSEcCtD
Acamprosate—Pain—Sibutramine—obesity	0.000256	0.000527	CcSEcCtD
Acamprosate—Constipation—Sibutramine—obesity	0.000256	0.000527	CcSEcCtD
Acamprosate—Thrombocytopenia—Bupropion—obesity	0.000256	0.000526	CcSEcCtD
Acamprosate—Feeling abnormal—Orlistat—obesity	0.000255	0.000524	CcSEcCtD
Acamprosate—Tachycardia—Bupropion—obesity	0.000255	0.000524	CcSEcCtD
Acamprosate—Stomatitis—Topiramate—obesity	0.000254	0.000523	CcSEcCtD
Acamprosate—Skin disorder—Bupropion—obesity	0.000253	0.000521	CcSEcCtD
Acamprosate—Urinary tract infection—Topiramate—obesity	0.000253	0.000521	CcSEcCtD
Acamprosate—Gastrointestinal pain—Orlistat—obesity	0.000253	0.00052	CcSEcCtD
Acamprosate—Hyperhidrosis—Bupropion—obesity	0.000252	0.000519	CcSEcCtD
Acamprosate—Anorexia—Bupropion—obesity	0.000249	0.000512	CcSEcCtD
Acamprosate—Haematuria—Topiramate—obesity	0.000249	0.000511	CcSEcCtD
Acamprosate—Feeling abnormal—Sibutramine—obesity	0.000247	0.000507	CcSEcCtD
Acamprosate—Epistaxis—Topiramate—obesity	0.000246	0.000506	CcSEcCtD
Acamprosate—Urticaria—Orlistat—obesity	0.000246	0.000505	CcSEcCtD
Acamprosate—Gastrointestinal pain—Sibutramine—obesity	0.000245	0.000504	CcSEcCtD
Acamprosate—Abdominal pain—Orlistat—obesity	0.000245	0.000503	CcSEcCtD
Acamprosate—Body temperature increased—Orlistat—obesity	0.000245	0.000503	CcSEcCtD
Acamprosate—Hypotension—Bupropion—obesity	0.000244	0.000502	CcSEcCtD
Acamprosate—Urticaria—Sibutramine—obesity	0.000238	0.000489	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Bupropion—obesity	0.000238	0.000489	CcSEcCtD
Acamprosate—Abdominal pain—Sibutramine—obesity	0.000237	0.000487	CcSEcCtD
Acamprosate—Body temperature increased—Sibutramine—obesity	0.000237	0.000487	CcSEcCtD
Acamprosate—Insomnia—Bupropion—obesity	0.000236	0.000486	CcSEcCtD
Acamprosate—Haemoglobin—Topiramate—obesity	0.000235	0.000484	CcSEcCtD
Acamprosate—Rhinitis—Topiramate—obesity	0.000235	0.000483	CcSEcCtD
Acamprosate—Paraesthesia—Bupropion—obesity	0.000234	0.000482	CcSEcCtD
Acamprosate—Haemorrhage—Topiramate—obesity	0.000234	0.000481	CcSEcCtD
Acamprosate—Hepatitis—Topiramate—obesity	0.000234	0.000481	CcSEcCtD
Acamprosate—Hypoaesthesia—Topiramate—obesity	0.000233	0.000479	CcSEcCtD
Acamprosate—Hallucination—Topiramate—obesity	0.000233	0.000479	CcSEcCtD
Acamprosate—Dyspnoea—Bupropion—obesity	0.000233	0.000479	CcSEcCtD
Acamprosate—Pharyngitis—Topiramate—obesity	0.000232	0.000478	CcSEcCtD
Acamprosate—Somnolence—Bupropion—obesity	0.000232	0.000477	CcSEcCtD
Acamprosate—Oedema peripheral—Topiramate—obesity	0.000231	0.000474	CcSEcCtD
Acamprosate—Dyspepsia—Bupropion—obesity	0.00023	0.000473	CcSEcCtD
Acamprosate—Hypersensitivity—Orlistat—obesity	0.000228	0.000469	CcSEcCtD
Acamprosate—Decreased appetite—Bupropion—obesity	0.000227	0.000467	CcSEcCtD
Acamprosate—Visual impairment—Topiramate—obesity	0.000226	0.000464	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Bupropion—obesity	0.000225	0.000463	CcSEcCtD
Acamprosate—Constipation—Bupropion—obesity	0.000223	0.000459	CcSEcCtD
Acamprosate—Pain—Bupropion—obesity	0.000223	0.000459	CcSEcCtD
Acamprosate—Asthenia—Orlistat—obesity	0.000222	0.000457	CcSEcCtD
Acamprosate—Hypersensitivity—Sibutramine—obesity	0.000221	0.000454	CcSEcCtD
Acamprosate—Pruritus—Orlistat—obesity	0.000219	0.00045	CcSEcCtD
Acamprosate—Tinnitus—Topiramate—obesity	0.000218	0.000449	CcSEcCtD
Acamprosate—Feeling abnormal—Bupropion—obesity	0.000215	0.000442	CcSEcCtD
Acamprosate—Asthenia—Sibutramine—obesity	0.000215	0.000442	CcSEcCtD
Acamprosate—Gastrointestinal pain—Bupropion—obesity	0.000213	0.000439	CcSEcCtD
Acamprosate—Pruritus—Sibutramine—obesity	0.000212	0.000436	CcSEcCtD
Acamprosate—Diarrhoea—Orlistat—obesity	0.000212	0.000435	CcSEcCtD
Acamprosate—Immune system disorder—Topiramate—obesity	0.000211	0.000435	CcSEcCtD
Acamprosate—Chills—Topiramate—obesity	0.00021	0.000432	CcSEcCtD
Acamprosate—Urticaria—Bupropion—obesity	0.000207	0.000426	CcSEcCtD
Acamprosate—Alopecia—Topiramate—obesity	0.000207	0.000425	CcSEcCtD
Acamprosate—Abdominal pain—Bupropion—obesity	0.000206	0.000424	CcSEcCtD
Acamprosate—Body temperature increased—Bupropion—obesity	0.000206	0.000424	CcSEcCtD
Acamprosate—Mental disorder—Topiramate—obesity	0.000205	0.000422	CcSEcCtD
Acamprosate—Diarrhoea—Sibutramine—obesity	0.000205	0.000421	CcSEcCtD
Acamprosate—Dizziness—Orlistat—obesity	0.000205	0.000421	CcSEcCtD
Acamprosate—Malnutrition—Topiramate—obesity	0.000204	0.000419	CcSEcCtD
Acamprosate—Flatulence—Topiramate—obesity	0.000201	0.000413	CcSEcCtD
Acamprosate—Tension—Topiramate—obesity	0.0002	0.000411	CcSEcCtD
Acamprosate—Dysgeusia—Topiramate—obesity	0.000199	0.00041	CcSEcCtD
Acamprosate—Dizziness—Sibutramine—obesity	0.000198	0.000407	CcSEcCtD
Acamprosate—Nervousness—Topiramate—obesity	0.000198	0.000407	CcSEcCtD
Acamprosate—Back pain—Topiramate—obesity	0.000197	0.000405	CcSEcCtD
Acamprosate—Vomiting—Orlistat—obesity	0.000197	0.000405	CcSEcCtD
Acamprosate—Muscle spasms—Topiramate—obesity	0.000196	0.000403	CcSEcCtD
Acamprosate—Rash—Orlistat—obesity	0.000195	0.000401	CcSEcCtD
Acamprosate—Dermatitis—Orlistat—obesity	0.000195	0.000401	CcSEcCtD
Acamprosate—Headache—Orlistat—obesity	0.000194	0.000399	CcSEcCtD
Acamprosate—Hypersensitivity—Bupropion—obesity	0.000192	0.000396	CcSEcCtD
Acamprosate—Tremor—Topiramate—obesity	0.000191	0.000393	CcSEcCtD
Acamprosate—Vomiting—Sibutramine—obesity	0.00019	0.000392	CcSEcCtD
Acamprosate—Ill-defined disorder—Topiramate—obesity	0.000189	0.000389	CcSEcCtD
Acamprosate—Rash—Sibutramine—obesity	0.000189	0.000388	CcSEcCtD
Acamprosate—Dermatitis—Sibutramine—obesity	0.000189	0.000388	CcSEcCtD
Acamprosate—Anaemia—Topiramate—obesity	0.000188	0.000387	CcSEcCtD
Acamprosate—Headache—Sibutramine—obesity	0.000188	0.000386	CcSEcCtD
Acamprosate—Asthenia—Bupropion—obesity	0.000187	0.000385	CcSEcCtD
Acamprosate—Agitation—Topiramate—obesity	0.000187	0.000385	CcSEcCtD
Acamprosate—Pruritus—Bupropion—obesity	0.000185	0.00038	CcSEcCtD
Acamprosate—Nausea—Orlistat—obesity	0.000184	0.000378	CcSEcCtD
Acamprosate—Malaise—Topiramate—obesity	0.000184	0.000378	CcSEcCtD
Acamprosate—Vertigo—Topiramate—obesity	0.000183	0.000377	CcSEcCtD
Acamprosate—Syncope—Topiramate—obesity	0.000183	0.000376	CcSEcCtD
Acamprosate—Leukopenia—Topiramate—obesity	0.000182	0.000375	CcSEcCtD
Acamprosate—Palpitations—Topiramate—obesity	0.00018	0.00037	CcSEcCtD
Acamprosate—Loss of consciousness—Topiramate—obesity	0.000179	0.000368	CcSEcCtD
Acamprosate—Diarrhoea—Bupropion—obesity	0.000179	0.000367	CcSEcCtD
Acamprosate—Nausea—Sibutramine—obesity	0.000178	0.000366	CcSEcCtD
Acamprosate—Cough—Topiramate—obesity	0.000178	0.000366	CcSEcCtD
Acamprosate—Convulsion—Topiramate—obesity	0.000176	0.000363	CcSEcCtD
Acamprosate—Hypertension—Topiramate—obesity	0.000176	0.000362	CcSEcCtD
Acamprosate—Myalgia—Topiramate—obesity	0.000173	0.000357	CcSEcCtD
Acamprosate—Arthralgia—Topiramate—obesity	0.000173	0.000357	CcSEcCtD
Acamprosate—Chest pain—Topiramate—obesity	0.000173	0.000357	CcSEcCtD
Acamprosate—Anxiety—Topiramate—obesity	0.000173	0.000356	CcSEcCtD
Acamprosate—Dizziness—Bupropion—obesity	0.000173	0.000355	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000172	0.000354	CcSEcCtD
Acamprosate—Discomfort—Topiramate—obesity	0.000171	0.000353	CcSEcCtD
Acamprosate—Dry mouth—Topiramate—obesity	0.00017	0.000349	CcSEcCtD
Acamprosate—Confusional state—Topiramate—obesity	0.000168	0.000345	CcSEcCtD
Acamprosate—Vomiting—Bupropion—obesity	0.000166	0.000341	CcSEcCtD
Acamprosate—Infection—Topiramate—obesity	0.000165	0.00034	CcSEcCtD
Acamprosate—Rash—Bupropion—obesity	0.000165	0.000338	CcSEcCtD
Acamprosate—Dermatitis—Bupropion—obesity	0.000164	0.000338	CcSEcCtD
Acamprosate—Shock—Topiramate—obesity	0.000164	0.000337	CcSEcCtD
Acamprosate—Headache—Bupropion—obesity	0.000163	0.000336	CcSEcCtD
Acamprosate—Thrombocytopenia—Topiramate—obesity	0.000163	0.000335	CcSEcCtD
Acamprosate—Tachycardia—Topiramate—obesity	0.000162	0.000334	CcSEcCtD
Acamprosate—Skin disorder—Topiramate—obesity	0.000161	0.000332	CcSEcCtD
Acamprosate—Hyperhidrosis—Topiramate—obesity	0.000161	0.000331	CcSEcCtD
Acamprosate—Anorexia—Topiramate—obesity	0.000158	0.000326	CcSEcCtD
Acamprosate—Hypotension—Topiramate—obesity	0.000155	0.00032	CcSEcCtD
Acamprosate—Nausea—Bupropion—obesity	0.000155	0.000319	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Topiramate—obesity	0.000151	0.000312	CcSEcCtD
Acamprosate—Insomnia—Topiramate—obesity	0.00015	0.000309	CcSEcCtD
Acamprosate—Paraesthesia—Topiramate—obesity	0.000149	0.000307	CcSEcCtD
Acamprosate—Dyspnoea—Topiramate—obesity	0.000148	0.000305	CcSEcCtD
Acamprosate—Somnolence—Topiramate—obesity	0.000148	0.000304	CcSEcCtD
Acamprosate—Dyspepsia—Topiramate—obesity	0.000146	0.000301	CcSEcCtD
Acamprosate—Decreased appetite—Topiramate—obesity	0.000145	0.000297	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Topiramate—obesity	0.000144	0.000295	CcSEcCtD
Acamprosate—Pain—Topiramate—obesity	0.000142	0.000292	CcSEcCtD
Acamprosate—Constipation—Topiramate—obesity	0.000142	0.000292	CcSEcCtD
Acamprosate—Feeling abnormal—Topiramate—obesity	0.000137	0.000282	CcSEcCtD
Acamprosate—Gastrointestinal pain—Topiramate—obesity	0.000136	0.00028	CcSEcCtD
Acamprosate—Urticaria—Topiramate—obesity	0.000132	0.000272	CcSEcCtD
Acamprosate—Abdominal pain—Topiramate—obesity	0.000131	0.00027	CcSEcCtD
Acamprosate—Body temperature increased—Topiramate—obesity	0.000131	0.00027	CcSEcCtD
Acamprosate—Hypersensitivity—Topiramate—obesity	0.000122	0.000252	CcSEcCtD
Acamprosate—Asthenia—Topiramate—obesity	0.000119	0.000245	CcSEcCtD
Acamprosate—Pruritus—Topiramate—obesity	0.000118	0.000242	CcSEcCtD
Acamprosate—Diarrhoea—Topiramate—obesity	0.000114	0.000234	CcSEcCtD
Acamprosate—Dizziness—Topiramate—obesity	0.00011	0.000226	CcSEcCtD
Acamprosate—Vomiting—Topiramate—obesity	0.000106	0.000217	CcSEcCtD
Acamprosate—Rash—Topiramate—obesity	0.000105	0.000216	CcSEcCtD
Acamprosate—Dermatitis—Topiramate—obesity	0.000105	0.000215	CcSEcCtD
Acamprosate—Headache—Topiramate—obesity	0.000104	0.000214	CcSEcCtD
Acamprosate—Nausea—Topiramate—obesity	9.88e-05	0.000203	CcSEcCtD
Acamprosate—GRM5—GPCR downstream signaling—HTR2A—obesity	9.03e-05	0.000372	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—C3—obesity	9.02e-05	0.000372	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HK2—obesity	9e-05	0.000371	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—MYC—obesity	9e-05	0.000371	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TGFB1—obesity	8.98e-05	0.000371	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—COMT—obesity	8.94e-05	0.000369	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—HTR2A—obesity	8.83e-05	0.000364	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—GNB3—obesity	8.82e-05	0.000364	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—MAPK8—obesity	8.81e-05	0.000363	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPY—obesity	8.8e-05	0.000363	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—SLC2A4—obesity	8.77e-05	0.000362	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IAPP—obesity	8.75e-05	0.000361	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOC3—obesity	8.75e-05	0.000361	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC27A1—obesity	8.63e-05	0.000356	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—APOA1—obesity	8.61e-05	0.000355	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—PRKCB—obesity	8.59e-05	0.000354	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BCHE—obesity	8.57e-05	0.000354	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AGT—obesity	8.57e-05	0.000353	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TRPV1—obesity	8.55e-05	0.000353	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—SLC2A4—obesity	8.55e-05	0.000353	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR1B—obesity	8.49e-05	0.00035	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CRH—obesity	8.49e-05	0.00035	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—obesity	8.44e-05	0.000348	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TRPV1—obesity	8.4e-05	0.000346	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SDC1—obesity	8.4e-05	0.000346	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—TNF—obesity	8.39e-05	0.000346	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCD—obesity	8.38e-05	0.000346	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—PRKCB—obesity	8.37e-05	0.000345	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NCOA1—obesity	8.36e-05	0.000345	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—STAT3—obesity	8.26e-05	0.000341	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKR1C3—obesity	8.26e-05	0.000341	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HK1—obesity	8.23e-05	0.00034	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HTR2A—obesity	8.2e-05	0.000338	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—C3—obesity	8.19e-05	0.000338	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NCOA1—obesity	8.15e-05	0.000336	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HK1—obesity	8.08e-05	0.000333	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—STAT3—obesity	8.05e-05	0.000332	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NPS—obesity	8.05e-05	0.000332	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—COMT—obesity	7.98e-05	0.000329	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FOXO3—obesity	7.96e-05	0.000328	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PRKCB—obesity	7.91e-05	0.000327	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—F2—obesity	7.91e-05	0.000327	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD1—obesity	7.89e-05	0.000326	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2C—obesity	7.89e-05	0.000326	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—GNB3—obesity	7.87e-05	0.000325	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—COMT—obesity	7.84e-05	0.000323	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AGT—obesity	7.78e-05	0.000321	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FOXO3—obesity	7.76e-05	0.00032	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—GNB3—obesity	7.73e-05	0.000319	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NTRK2—obesity	7.68e-05	0.000317	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB1—obesity	7.65e-05	0.000315	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—PIK3R1—obesity	7.64e-05	0.000315	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CG—obesity	7.57e-05	0.000313	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARGC1A—obesity	7.56e-05	0.000312	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GHRL—obesity	7.48e-05	0.000309	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PARP1—obesity	7.48e-05	0.000309	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD4—obesity	7.42e-05	0.000306	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—PRKCB—obesity	7.4e-05	0.000305	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARGC1A—obesity	7.37e-05	0.000304	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TRPV1—obesity	7.34e-05	0.000303	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC22A1—obesity	7.27e-05	0.0003	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—PRKCB—obesity	7.26e-05	0.0003	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—POMC—obesity	7.21e-05	0.000297	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PRKCB—obesity	7.19e-05	0.000297	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—F2—obesity	7.19e-05	0.000297	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC22A1—obesity	7.14e-05	0.000295	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CNR1—obesity	7.09e-05	0.000292	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HK1—obesity	7.07e-05	0.000291	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MTOR—obesity	7.05e-05	0.000291	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TCF7L2—obesity	6.96e-05	0.000287	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT2—obesity	6.93e-05	0.000286	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—DRD2—obesity	6.91e-05	0.000285	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LPL—obesity	6.88e-05	0.000284	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—obesity	6.88e-05	0.000284	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—COMT—obesity	6.85e-05	0.000283	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTPN1—obesity	6.85e-05	0.000282	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GCG—obesity	6.85e-05	0.000282	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FOXO1—obesity	6.83e-05	0.000282	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—obesity	6.82e-05	0.000282	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—obesity	6.77e-05	0.000279	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—GNB3—obesity	6.76e-05	0.000279	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PRKAR2B—obesity	6.71e-05	0.000277	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—obesity	6.71e-05	0.000277	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LPL—obesity	6.71e-05	0.000277	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—obesity	6.66e-05	0.000275	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FOXO1—obesity	6.66e-05	0.000275	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PRKAR2B—obesity	6.59e-05	0.000272	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—POMC—obesity	6.55e-05	0.00027	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CD36—obesity	6.54e-05	0.00027	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRL—obesity	6.53e-05	0.000269	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STK11—obesity	6.44e-05	0.000266	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CCL2—obesity	6.41e-05	0.000264	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CD36—obesity	6.37e-05	0.000263	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PLG—obesity	6.36e-05	0.000263	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—RHOA—obesity	6.35e-05	0.000262	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—PRKCB—obesity	6.35e-05	0.000262	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GCK—obesity	6.32e-05	0.000261	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT2—obesity	6.29e-05	0.00026	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3R1—obesity	6.29e-05	0.000259	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC22A1—obesity	6.24e-05	0.000257	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FOXO3—obesity	6.21e-05	0.000256	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GCK—obesity	6.2e-05	0.000256	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ADRB2—obesity	6.19e-05	0.000256	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—TYK2—obesity	6.17e-05	0.000254	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—RHOA—obesity	6.12e-05	0.000252	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SOCS1—obesity	6.1e-05	0.000252	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CETP—obesity	6.09e-05	0.000251	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARA—obesity	6.08e-05	0.000251	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—obesity	6.05e-05	0.000249	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SOCS3—obesity	6.03e-05	0.000249	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TF—obesity	6.02e-05	0.000249	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—TYK2—obesity	6.01e-05	0.000248	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CETP—obesity	5.98e-05	0.000247	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—RHOA—obesity	5.96e-05	0.000246	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK8—obesity	5.96e-05	0.000246	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARA—obesity	5.92e-05	0.000244	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TF—obesity	5.92e-05	0.000244	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GNB3—obesity	5.9e-05	0.000243	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—TYK2—obesity	5.82e-05	0.00024	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—obesity	5.8e-05	0.000239	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF2—obesity	5.79e-05	0.000239	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—TFRC—obesity	5.78e-05	0.000238	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—RHOA—obesity	5.77e-05	0.000238	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—LEP—obesity	5.77e-05	0.000238	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PRKAR2B—obesity	5.76e-05	0.000238	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GNAS—obesity	5.74e-05	0.000237	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3R1—obesity	5.71e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—TFRC—obesity	5.67e-05	0.000234	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCB—obesity	5.67e-05	0.000234	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOB—obesity	5.63e-05	0.000232	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—LEP—obesity	5.62e-05	0.000232	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCB—obesity	5.56e-05	0.00023	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL5—obesity	5.49e-05	0.000227	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—obesity	5.45e-05	0.000225	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GCK—obesity	5.42e-05	0.000224	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—obesity	5.41e-05	0.000223	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LPL—obesity	5.37e-05	0.000222	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FOXO1—obesity	5.33e-05	0.00022	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—obesity	5.32e-05	0.00022	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RPS6KB1—obesity	5.32e-05	0.00022	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—obesity	5.27e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL1B—obesity	5.23e-05	0.000216	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CETP—obesity	5.23e-05	0.000216	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—obesity	5.19e-05	0.000214	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TF—obesity	5.17e-05	0.000213	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—obesity	5.02e-05	0.000207	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—TFRC—obesity	4.96e-05	0.000205	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCD—obesity	4.95e-05	0.000204	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—INS—obesity	4.93e-05	0.000203	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC2A4—obesity	4.91e-05	0.000203	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—obesity	4.9e-05	0.000202	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCB—obesity	4.86e-05	0.000201	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—obesity	4.86e-05	0.0002	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—CYCS—obesity	4.85e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HTR2A—obesity	4.84e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—C3—obesity	4.84e-05	0.0002	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC2A4—obesity	4.82e-05	0.000199	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—INS—obesity	4.8e-05	0.000198	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT2—obesity	4.76e-05	0.000196	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—CYCS—obesity	4.76e-05	0.000196	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—obesity	4.74e-05	0.000195	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—NCOA1—obesity	4.69e-05	0.000193	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT2—obesity	4.64e-05	0.000192	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—NCOA1—obesity	4.6e-05	0.00019	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRS2—obesity	4.6e-05	0.00019	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AGT—obesity	4.6e-05	0.00019	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PLG—obesity	4.57e-05	0.000188	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOE—obesity	4.5e-05	0.000186	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—LEP—obesity	4.5e-05	0.000186	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PLG—obesity	4.48e-05	0.000185	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CAV1—obesity	4.46e-05	0.000184	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APOA1—obesity	4.45e-05	0.000184	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TYK2—obesity	4.4e-05	0.000182	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RHOA—obesity	4.37e-05	0.00018	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ESR1—obesity	4.3e-05	0.000177	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TYK2—obesity	4.29e-05	0.000177	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RHOA—obesity	4.26e-05	0.000176	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCB—obesity	4.25e-05	0.000175	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—F2—obesity	4.25e-05	0.000175	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNB3—obesity	4.23e-05	0.000175	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC2A4—obesity	4.22e-05	0.000174	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—HMOX1—obesity	4.21e-05	0.000174	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BAD—obesity	4.2e-05	0.000173	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—CYCS—obesity	4.16e-05	0.000172	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNB3—obesity	4.16e-05	0.000172	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—HMOX1—obesity	4.14e-05	0.000171	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—GNAS—obesity	4.12e-05	0.00017	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—obesity	4.06e-05	0.000168	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—GNAS—obesity	4.05e-05	0.000167	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOB—obesity	4.04e-05	0.000167	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—NCOA1—obesity	4.02e-05	0.000166	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IRS1—obesity	4.02e-05	0.000166	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOB—obesity	3.96e-05	0.000164	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PLG—obesity	3.92e-05	0.000162	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—POMC—obesity	3.87e-05	0.00016	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—INS—obesity	3.85e-05	0.000159	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—obesity	3.8e-05	0.000157	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCL2—obesity	3.78e-05	0.000156	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—obesity	3.72e-05	0.000153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT2—obesity	3.72e-05	0.000153	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNB3—obesity	3.63e-05	0.00015	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—HMOX1—obesity	3.62e-05	0.000149	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—obesity	3.57e-05	0.000147	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—obesity	3.54e-05	0.000146	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—GNAS—obesity	3.54e-05	0.000146	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SERPINE1—obesity	3.53e-05	0.000146	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—obesity	3.51e-05	0.000145	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—obesity	3.47e-05	0.000143	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOB—obesity	3.46e-05	0.000143	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TYK2—obesity	3.44e-05	0.000142	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RHOA—obesity	3.41e-05	0.000141	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—PPARA—obesity	3.4e-05	0.00014	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—obesity	3.38e-05	0.000139	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3R1—obesity	3.37e-05	0.000139	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOS3—obesity	3.37e-05	0.000139	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—PPARA—obesity	3.34e-05	0.000138	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—obesity	3.21e-05	0.000133	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—APOA1—obesity	3.19e-05	0.000132	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—APOA1—obesity	3.14e-05	0.000129	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MTOR—obesity	3.11e-05	0.000128	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—obesity	3.11e-05	0.000128	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—obesity	3.08e-05	0.000127	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—obesity	3.07e-05	0.000126	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—obesity	3.02e-05	0.000124	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—obesity	3e-05	0.000124	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—obesity	2.94e-05	0.000121	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—PPARA—obesity	2.92e-05	0.000121	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—obesity	2.89e-05	0.000119	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TGFB1—obesity	2.86e-05	0.000118	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—obesity	2.85e-05	0.000117	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TGFB1—obesity	2.78e-05	0.000115	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—APOA1—obesity	2.74e-05	0.000113	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—obesity	2.71e-05	0.000112	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—obesity	2.67e-05	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK8—obesity	2.63e-05	0.000109	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—obesity	2.62e-05	0.000108	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—obesity	2.6e-05	0.000107	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—obesity	2.53e-05	0.000104	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—obesity	2.48e-05	0.000103	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—obesity	2.41e-05	9.93e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—obesity	2.24e-05	9.22e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TGFB1—obesity	2.23e-05	9.2e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—obesity	2.17e-05	8.96e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—obesity	2.15e-05	8.88e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—obesity	2.1e-05	8.66e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—obesity	1.99e-05	8.19e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—obesity	1.94e-05	7.99e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—obesity	1.9e-05	7.83e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—obesity	1.68e-05	6.93e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—obesity	1.55e-05	6.4e-05	CbGpPWpGaD
